Skip to main content
. Author manuscript; available in PMC: 2019 Nov 19.
Published in final edited form as: ACS Chem Neurosci. 2018 Dec 3;10(3):1595–1602. doi: 10.1021/acschemneuro.8b00543

Table 1.

DKR-1677 Binding Profile at Non-Sigma Receptor Sitesa

target Ki (nM) target Ki (nM)
5HT1A 1187 Beta2 >10 000
5HT1B >10 000 Beta3 >10 000
5HT1D 1913 BZP rat brain 4767
5HT1e 7741 D1 >10 000
5HT2A 1274 D2 >3253
5HT2B 868 D3 4426
5HT2C 2138 D4 >10 000
5HT3 >10 000 D5 4888
5HT5a 3238 DAT 2080
5HT6 2510 DOR >10 000
5HT7 766 GabaA >10 000
A2B2 b H1 100
A2B4 b H2 1766
A3B2 b H3 644
A3B4 b H4 >10 000
A4B2 b hERG 695
A4B2c b KOR 8515
A4B4 b M1 4062
A7 b M2 4326
A7c b M3 1114
Alpha1a 2667 M4 1634
Alpha1b >10 000 M5 1395
Alpha1d 1905 MOR 8798
Alpha2a 340 NET 3845
Alpha2b 1799 NMDA 10 000
Alpha2c 539 PBR >10 000
Beta1 6282 SERT 8630
a

Receptor binding assays were performed by the Psychoactive Drug Screening Program (PDSP)at Chapel Hill, North Carolina. The assay protocol book can be accessed free of charge at: https://pdspdb.unc.edu/pdspWeb/content/PDSP%20Protocols%20II%202013-03-28.pdf. Values represented are single Ki determination.

b

<50% inhibition of radioligand binding at 10 μM.

c

Sourced from rodent brain.